XML 44 R34.htm IDEA: XBRL DOCUMENT
v3.25.3

Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Information [Abstract] |
Segment Information | The following table sets forth information on segment profit or loss, including significant segment expenses (in thousands):
| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
|  | 2025 |  |  |  | 2024 |  |  |  | 2025 |  |  |  | 2024 |
Revenue | $ | 156,719 |  |  | $ | 133,814 |  |  | $ | 740,381 |  |  | $ | 478,562 |
Less: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of sales |  | 2,193 |  |  |  | 912 |  |  |  | 7,097 |  |  |  | 6,815 |
Drug discovery |  | 28,412 |  |  |  | 25,790 |  |  |  | 85,656 |  |  |  | 80,652 |
Drug development |  | 120,828 |  |  |  | 132,201 |  |  |  | 351,463 |  |  |  | 392,151 |
Medical affairs |  | 8,874 |  |  |  | 5,511 |  |  |  | 22,342 |  |  |  | 17,279 |
Manufacturing and development chemistry |  | 15,790 |  |  |  | 14,087 |  |  |  | 51,616 |  |  |  | 39,723 |
R&D support |  | 23,092 |  |  |  | 20,052 |  |  |  | 64,252 |  |  |  | 59,065 |
Selling, general and administrative |  | 86,565 |  |  |  | 51,933 |  |  |  | 234,626 |  |  |  | 153,083 |
Other segment items (1) |  | (429 | ) |  |  | 23,808 |  |  |  | 75,322 |  |  |  | 79,342 |
Consolidated net loss | $ | (128,606 | ) |  | $ | (140,480 | ) |  | $ | (151,993 | ) |  | $ | (349,548 | )
(1) Other segment items include stock-based compensation expense, investment income, interest expense, gain or loss on investments, other income or expense and income tax expense or benefit.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration